Items where Funder is Novartis Pharmaceuticals UK Ltd.

The University of Leeds

Lorés-Motta, L, Riaz, M, Grunin, M et al. (31 more authors) (2018) Association of Genetic Variants With Response to Anti–Vascular Endothelial Growth Factor Therapy in Age-Related Macular Degeneration. JAMA Ophthalmology, 136 (8). pp. 875-884. ISSN 2168-6165

Bridgewood, C, Watad, A, Russell, T et al. (10 more authors) (2019) Identification of myeloid cells in the human enthesis as the main source of local IL-23 production. Annals of the rheumatic diseases, 78 (7). pp. 929-933. ISSN 0003-4967

Rowe, H, Watad, A, Bridgewood, C et al. (9 more authors) (2019) In Vitro Human Enthesitis Model with Induced IL-17A and TNF alpha from CD4+and CD8+T Cells and Effect of Pharmacological Antagonism with Janus Kinase and Retinoic Acid Receptor-related Orphan Receptor gamma Inhibition. In: 2019 ACR/ARP Annual Meeting, 08-13 Nov 2019, Atlanta, GA, USA.

Watad, A, Rowe, H, Newton, D orcid.org/0000-0002-0214-1486 et al. (2 more authors) (2022) Response to: ‘Beware of wolves in sheep's clothing: immune cell plasticity and instability in health and disease’ by Alunno et al. Annals of the Rheumatic Diseases, 81 (7). e130. ISSN 0003-4967

Rowe, H, Watad, A, Russell, T et al. (13 more authors) (2020) SAT0361 HEALTHY HUMAN SPINAL PROCESSES PERI-ENTHESEAL T-CELLS EXHIBIT A TR1 RATHER THAN A FOXP3 REGULATORY PHENOTYPE. In: EULAR 2020, 03-06 Jun 2020, Online.

The University of Sheffield

Mildred, M., Ward, S., Squires, H. et al. (1 more author) (2012) Cost-effectiveness analysis of nilotinib versus imatinib for the treatment of chronic phase philadelphia chromosome positive chronic myeloid leukaemia. In: 17th Congress of EHA, 14-17 Jun 2012, Amsterdam, The Netherlands.

Mildred, Matthew, Ward, Sue, Squires, Hazel et al. (1 more author) (2012) Decision modelling using time on treatment data: evaluating the survival benefit of nilotinib versus imatinib in patients with chronic phase Ph+ CML. In: 9th Annual Health Technology Assessment Society (HTAi) Meeting, 25-27 Jun 2012, Bilbao, Spain.